Wells Fargo lowered the firm’s price target on Elevance Health (ELV) to $495 from $593 and keeps an Overweight rating on the shares. Following the bulk of earnings, the firm
Wells Fargo lowered the firm’s price target on Elevance Health (ELV) to $495 from $593 and keeps an Overweight rating on the shares. Following the bulk of earnings, the firm